Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Troglitazone

Catalog No. ABIN1027861
$248.40
Plus shipping costs $50.00
Shipping to: United States
Delivery in 3 to 5 Business Days

Quick Overview for Troglitazone (ABIN1027861)

  • Purpose

    PPARgamma agonist

    Characteristics

    PPARgamma agonist.

    Purity

    >98 %

    Chemical Name

    5-{4-[(6-Hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl)methoxy]benzyl}-1,3-thiazolidine-2,4-dione, Rezulin

    Formula

    C24H27NO5S

    Solubility

    Soluble to 100 mM in DMSO and to 10 mM in ethanol
  • Comment

    Source: Synthetic.
    Appearance: White solid

    Restrictions

    For Research Use only
  • Format

    Solid

    Precaution of Use

    Classification: Harmful. May be harmful if inhaled, swallowed or absorbed through skin. Safety Phrases: S22 - Do not breathe dust S24/25 - Avoid contact with skin and eyes S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection Risk Phrases: R20/21/22 - Harmful by inhalation, in contact with skin and if swallowed R40 - Limited evidence of a carcinogenic effect

    Handling Advice

    Classification: Harmful. May be harmful if inhaled, swallowed or absorbed through skin. Safety Phrases: S22 - Do not breathe dust S24/25 - Avoid contact with skin and eyes S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection Risk Phrases: R20/21/22 - Harmful by inhalation, in contact with skin and if swallowed R40 - Limited evidence of a carcinogenic effect

    Storage

    -20 °C
  • Background

    Troglitazone, a member of the thaizolidinediones, is an anti-diabetic and anti-inflammatory drug. It works by activating peroxisome proliferator-activated receptors (PPARs). It is a ligand to both PPARalpha and gamma. It also contains an alpha-tocopheroyl moiety, potentially giving it vitamin E like activity (which helps in inflammation).
    Synonyms: Rezulin

    Molecular Weight

    441.54

    CAS-No

    97322-87-7
You are here:
Chat with us!